Lilly Releases 2017 Integrated Summary Report

Lilly is innovating beyond the medicines we create to improve lives. We are committed to expanding access to medicines in the U.S. health care system, in part by providing greater transparency about how we price our products.

Last year, we announced plans to make it easier for patients, physicians, policymakers, and others to understand our pricing and our efforts to help make our medicines affordable.

 Information about Lilly’s list and net prices, and rebates and discounts, is once again included in the 2017 Lilly Integrated Summary Reportwhich we released today.